Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 05, 2025 17:37 ET | Source: 22nd Century Group, Inc.

22nd Century to Participate in the HC Wainwright Conference in New York City September 9, 2025

MOCKSVILLE, N.C., Sept. 05, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the...
September 03, 2025 08:30 ET | Source: Journey Medical Corporation

Journey Medical Corporation to Participate in September 2025 Investor Conferences

SCOTTSDALE, Ariz., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on...
September 03, 2025 08:00 ET | Source: GCL Global Holdings Ltd.

GCL to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

GCL to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 02, 2025 08:30 ET | Source: Fortress Biotech, Inc.

Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference

MIAMI, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...
May 07, 2025 08:00 ET | Source: Fortress Biotech, Inc.

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference

MIAMI, May 07, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...
September 09, 2024 07:30 ET | Source: Theratechnologies

Theratechnologies fera des présentations aux conférences d'investisseurs en septembre

MONTRÉAL, 09 sept. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une entreprise biopharmaceutique axée sur la mise au...
September 09, 2024 07:30 ET | Source: Theratechnologies

Theratechnologies to Present at Upcoming Investor Conferences in September

MONTREAL, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
September 05, 2024 07:03 ET | Source: Unicycive Therapeutics, Inc.

Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

LOS ALTOS, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
September 04, 2024 08:30 ET | Source: Fortress Biotech, Inc.

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

MIAMI, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...
August 08, 2024 07:05 ET | Source: Clearside Biomedical, Inc.

Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

ALPHARETTA, Ga., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...